Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Developing drugs targeting the PI3K/AKT signalling

Date

10 Oct 2016

Session

Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents

Presenters

Li Yan

Authors

L. Yan

Author affiliations

  • GSK Oncology, Collegeville/US
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Resources from the same session

Introduction

Presenter: Roger Stupp

Session: Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents

Resources:

Presentation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings